BMB Reports 2024; 57(8): 369-374  https://doi.org/10.5483/BMBRep.2024-0056
Structural stability for surface display of antigen 43 and application to bacterial outer membrane vesicles production
Gna Ahn1,2,# , Hyo-Won Yoon1,# , Jae-Won Choi3,# , Woo-Ri Shin1,4 , Jiho Min5,* , Yang-Hoon Kim1,* & Ji-Young Ahn1,2,*
1Department of Microbiology, Chungbuk National University, Cheongju 28644, 2Center for Ecology and Environmental Toxicology, Chungbuk National University, Cheongju 28644, 3Department of Biopharmaceutical Sciences, Cheongju University, Cheongju 28160, Korea, 4Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA, 5Graduate School of Semiconductor and Chemical Engineering, Jeonbuk National University, Jeonju 54896, Korea
Correspondence to: Jiho Min, Tel: +82-63-270-2436; Fax: +82-63-270-2306; E-mail: jihomin@jbnu.ac.kr; Yang-Hoon Kim, Tel: +82-43-261-3575; Fax: +82-43-264-9600; E-mail: kyh@chungbuk.ac.kr; Ji-Young Ahn, Tel: +82-43-261-2301; Fax: +82-43-264-9600; E-mail: jyahn@chungbuk.ac.kr
#These authors contributed equally to this work.
Received: April 15, 2024; Revised: April 29, 2024; Accepted: May 10, 2024; Published online: June 26, 2024.
© Korean Society for Biochemistry and Molecular Biology. All rights reserved.

cc This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT
Antigen 43 (Ag43) proteins, found on the outer membrane of Escherichia coli, are β-sheets that fold into a unique cylindrical structure known as a β-barrel. There are several known structural similarities between bacterial Ag43 autotransporters and physical components; however, the factors that stabilize the barrel and the mechanism for Ag43 passenger domainmediated translocation across the pore of the β-barrel remain unclear. In this study, we analyzed Ag43β-enhanced green fluorescent protein chimeric variants to provide new insights into the autotransporter Ag43β-barrel assembly, focusing on the impact of the α-helical linker domain. Among the chimeric variants, Ag43β700 showed the highest surface display, which was confirmed through extracellular protease digestion, flow cytometry, and an evaluation of outer membrane vesicles (OMVs). The Ag43β700 module offered reliable information on stable barrel folding and chimera expression at the exterior of the OMVs.
Keywords: Antigen 43, Autotransporter, Outer membrane vesicle, Surface display, α-helical linker domain
INTRODUCTION

The gram-negative bacterium Escherichia coli possesses various protein secretion systems (SS), including types I-VI (T1SS-T6SS) and type VIII (T8SS). Among these, the T5SS system-especially T5SSa, an autotransporter (AT) pathway-stands out as the simplest polyprotein related to protein secretion, comprising three functional domains—an inner membrane transport domain, a passenger domain on the surface, and a β-domain that serves as a translocation pore for the passenger domain (1).

Antigen 43 (Ag43), which belongs to the T5SSa system, is expressed on the surface of E. coli outer membrane (OM) in an embedded state and functions in cell aggregation and biofilm formation (2). Ag43 is a high-copy expression system (> 50,000 copies per cell) (3) and, has been used in several applications for the display of various recombinant proteins (4-6). Ag43 was initially synthesized as a 1,039 amino acid (aa)-long polypeptide consisting of a signal peptide (SP), passenger domain, and translocation unit (TU) (6). TUs consist of a concentric α-helical linker domain (α-HLD) and a 12 β-subunit, which form a stable pore-like barrel structure on the OM, leading to an exterior orientation of the passenger domain in the transmembrane cylindrical pore (7). While TUs share structural characteristics, their ability to display heterologous proteins on the surface varies markedly. Understanding Ag43β-barrel (Ag43β) structures would provide an insight into the utility of the Ag43 AT system for producing engineered biomaterials.

Although the domains and common architectures of Ag43β have been studied, the Ag43β expression module has not been extensively characterized, prompting us to systematically investigate this aspect. We used the Molecular Operating Environment (MOE) for protein structure modeling to show that the α-HLD of the Ag43β TU effectively forms stable hydrogen bonds with neighboring β-strands. While the structure of the full-length Ag43β from E. coli has not been reported to date, MOE allows three-dimensional molecular visualization of Ag43β through sequence-to-structure prediction and intermolecular docking characterization (8, 9).

Bacterial outer membrane vesicles (OMVs) are lipid-bilayer membrane nanovesicles formed by the bulging and pinching-off of a portion of the OM. They contain biologically active components typically found in the gram-negative OM and offer several advantages as nanocarriers (10). To date, nanoscale OMVs have been exploited as attractive immune boosters, in drug delivery, for intra/inter-species communication, etc. (11-13). OMVs can be systematically engineered to express heterogeneous proteins, offering the possibility of acquiring OMVs with exterior or interior display of chimeric proteins.

The yield of naturally released OMVs (nOMVs) is often too low for therapeutic or industrial applications. Strategies to increase OMV yields have been developed based on gene disruption using the Tol-Pal system (14), mutation of lipopolysaccharide (LPS) (15), and physical or chemical treatments (16). In this study, we isolated and purified OMVs using a lysozyme-based detergent (LD-OMVs).

To systematically analyze whether Ag43β variants can be used as a platform for the simultaneous display of chimeric proteins, we generated fluorescent chimeras using genetic fusion of the Ag43β variants with enhanced green fluorescent protein (eGFP). Next, LD-OMVs were compared with nOMVs to assess whether these LD-OMVs would have higher yield than that of nOMVs for the engineering of bacteria carrying Ag43β variants to produce the desired target.

RESULTS

Chimeric Ag43β surface display model construction

E. coli Ag43β is a well-known bacterial AT that functions via self-recognition of the passenger domains. Ag43β AT polypeptides are 1,039 aa long and contain the following: a signal peptide (SP; aa 1-52), an N-terminal unstructured domain of unknown function (aa 53-138), a functional passenger domain (aa 139-600) with a proteolytic cleavage site at residue 552, an autochaperone (AC) domain (aa 601-700), an α-HLD (aa 701-740), and a C-terminal β-barrel (aa 741-1,039) (Fig. 1A). The β-barrel assembly machinery catalyzes the essential β-barrel insertion into the OM. The C-terminal β-barrel pore is necessary for the translocation of the functional passenger domain to the cell exterior (17). The AC domain is required for proper extracellular folding and secretion in numerous ATs. However, some studies have demonstrated that stable surface display of heterologous globular proteins can be accomplished in the absence of both the native passenger and AC domains (6, 17). The inconsistencies in the literature regarding the AC domain prompted us to further investigate the relevance of this structural element in Ag43β.

To explore the influence of crucial components of the Ag43β surface display system, we designed a series of truncated variants of Ag43β. Supplementary Fig. 1 shows the domain organization of Ag43β and the structures of the following generated plasmids: Ag43β138_eGFP, Ag43β552_eGFP, Ag43β700_eGFP, Ag43β740_eGFP, and Ag43β926_eGFP. Ag43β138_eGFP encodes the native Ag43 SP, Ag43 amino acids 138 through 1,039, and eGFP. In order to investigate the minimum surface display module, the downstream regions of the passenger domain (aa 552-600), native Ag43 AC region (aa 601-700), and α-HLD in the TU (aa 701-740) were deleted. Finally, to assess the potential for maintaining the β-barrel anchor, the N-terminal β-barrel compartments (aa 741-926) were deleted. All transformants were successfully expressed and observed on the basis of their fluorescence in cells (data not shown). However, the expression of Ag43β_eGFP was insufficient to provide information on the extracellular surface display.

The functionality of eGFP fused with the Ag43β variants was assessed using flow cytometry (Fig. 1B). Recombinant bacterial cells bearing the Ag43β variants Ag43β700_eGFP and Ag43β740_eGFP were grown and induced overnight to trigger eGFP expression and surface display. Cells harboring Ag43β700_eGFP had a significant double-positive eGFP/Alexa FlourTM 647 area (Q1) of 70.19%, whereas that of cells harboring Ag43β740_eGFP was 13.26%.

To assess whether eGFP was displayed on the exterior or interior, we carried out extracellular protease digestion (Supplementary Fig. 2). Targets of interest are accessible to extracellular trypsin if displayed on the exterior of the cell but remain resistant when trapped beneath the cellular membrane; periplasmic or cytoplasmic eGFP is not degraded unless the bacterial cells are lysed by treatment with proteases and detergents. Fig. 1C shows SDS-PAGE and western blot results for eGFP from trypsin-treated (+) and non-treated (−) cells. The most significant decrease in band intensity, compared to that in the non-treated control was observed for cells expressing Ag43β700_eGFP. Therefore, Ag43β700 can effectively present chimeric proteins on the exterior of the OM. In the case of Ag43β740_eGFP, eGFP remained largely undigested even at high trypsin concentrations (up to 1 μg/ml), consistent with flow cytometry results. Ag43β926_eGFP exhibited greater resistance to trypsin digestion, as shown in Supplementary Fig. 2, which suggested that the eGFP was trapped in the bacterial periplasm. Additionally, Ag43β926_eGFP showed low expression levels. Therefore, we hypothesized that Ag43β926_eGFP probably did not form a complete β-barrel structure. Owing to the absence of the α-HLD, the eGFP may not be inserted into the membrane and could potentially float freely in the periplasm. These observations led us to investigate eGFP translocation across the β-barrel pore (Fig. 1D). We found that the embedded α-HLD was necessary for the insertion of chimeras into the β-barrel pore, indicating its crucial structural role. Furthermore, in the α-HLD deletion variant Ag43β740, β-barrel strands led to the retention of the chimeric proteins in the periplasm. This affected both structural plasticity and periplasmic degradability.

α-HLD is an essential cue for achieving surface display and Ag43β machinery

The C-terminal TU consists of a β-barrel and an α-HLD. While these structures enable Ag43β to mediate extracellular display through transmembrane pore formation, they offer limited insights into the exterior orientation of Ag43-mediated surface display. The Ag43β700_eGFP construct included a native TU, including the α-HLD, whereas Ag43β740_eGFP did not. Initial studies using cells harboring Ag43β700_eGFP indicated that functional surface display of eGFP could be achieved in this context. Therefore, we next systematically investigated the contribution of α-HLD in the TU.

The three-dimensional structure of the TU predicts a central α-HLD (aa 701-740) winding through an antiparallel 12-strand β-barrel. The TU also shows a fully zipped conformation between its C-terminal strand (β12) and strand β1 (Fig. 2A, strands colored in green). The α-HLD, as indicated by its topological features and amino acid sequence, comprises two interfacing parts—a pore-facing plug (V727-E740) and a pore-releasing tip (R701-V726). Interestingly, the pore-releasing tip is positioned at the top edge of the β-barrel domain, extending in an elongated conformation toward the external environment. In the pore-facing bridge region, residues G729, R731, H733, Q734, and E740 are located near the periplasmic end of the barrel strands, engaging in hydrogen-bond interactions with the internal residues R777, E779, N830, E872, Q890, Q998, and R1004 in strands β2, β4, β6, β7, and β10 (Fig. 2B, C, and Supplementary Fig. 3). These findings reveal that the conformational assembly necessitates the burial of the pore-facing plug into the internal cavity. Therefore, it is most plausible that α-HLD serves as the hinge linker for recruiting the protein of interest into the proximity of the primed β-strand pore for spontaneous integration. Accordingly, α-HLD may be essential for the stable conformation of the β-barrel structure.

Enhanced purification yield of OMVs and extracellular targeting of Ag43β-eGFP on the OMVs

Gram-negative bacteria naturally release OMVs with typical OM compositions, including LPS, phospholipids, and OM proteins. The potential therapeutic applications of engineered OMVs have been described (12, 18). Furthermore, OMVs have been utilized as carriers for exogenous enzymes in bioremediation and industrial applications (19). In the present study, we adopted the lysozyme-based detergent isolation technique (Fig. 3A) and compared it to the common isolation method involving nOMVs (Table 1). Both LD-OMVs and nOMVs showed no differences in terms of OMV particle size. However, the LD-OMVs displayed significantly higher particle concentrations than those isolated using nOMVs.

Measurements on the basis of cryo-TEM images revealed a range of Ag43β variant LD-OMVs, with diameters approximately 240 nm, consistent with the OMV particle diameter measured using the qNano Gold system (Fig. 3B). Extracellular trypsin treatment of LD-Ag43β700_eGFP-OMVs and LD-Ag43β740_eGFP-OMVs produced different band patterns as observed after bacterial trypsin treatment (Fig. 3C).

Furthermore, a comparison of the two OMV purification methods revealed the presence of internal components. A recent study demonstrated the presence of common cytoplasmic proteins in culture-derived OMVs (10). Moreover, the possibility of gene transfer between bacteria and host cells via OMVs has been reported (20, 21). This suggests that OMV-associated genetic materials may play an important role in bacterial pathogenesis. Analysis of OMV-derived 16s rDNA showed high levels of bacterial DNA amplification in nOMVs, which was not observed in LD-OMVs (Fig. 3D).

DISCUSSION

This study demonstrated that the bacterial Ag43β AT platform facilitates efficient presentation of heterologous chimeric proteins on the OM and OMV surfaces. Our first strategy, using truncated Ag43β forms fused with eGFP, allowed straightforward characterization of the key components of the β-barrel scaffold, based on the basic β-barrel topology, using MOE prediction. Based on MOE evaluation of the Ag43β truncation variants, we speculated that the α-HLD facilitated the translocation of eGFP to the cell exterior. In this scenario, Ag43β700-eGFP correctly recruits eGFP to the surface, leading to the interaction of the α-HLD with several β-strands (β2, β4, β6, β7, and β10, see Fig. 2B). In contrast, Ag43β740-eGFP showed intracellular trapping. In addition, we found an abrupt alteration in Ag43β926-eGFP due to the lack of support from periplasmic plugs (N-terminal strands β1 to β8), perturbing the formation of the membrane spanning pore.

The second approach we used to understand the Ag43β AT was to use OMVs containing the OM-associated bacterial compartment. OMVs produced by gram-negative bacteria have been widely investigated for application as biomimetic nanocarriers because they are engineerable. We developed two Ag43β-derived modules (Ag43β700-eGFP and Ag43β740-eGFP) to target chimera to different OMV compartments, including the lumen and the outer surface. Early studies on this topic have shown that enzymatic activity can be preserved through OMV-luminal enzyme localization (19, 22). Furthermore, antigens presented on the surfaces of OMVs can be phagocytosed via the pathogen-associated pattern recognition system to stimulate a strong and specific immune response (23, 24). However, important drawbacks of these applications are their low OMV yield and the toxicity of LPS. Current approaches involve using a genetically modified vesicle-overproducing host and detergent extraction, which reduces the content of reactogenic LPS (14-16, 25). However, detergent extraction leads to the removal of chimeric components (26) and promotes vesicle aggregation by altering the OMV structure (27). Recent efforts to improve OMV extraction have focused on novel techniques that allow chimeric functionality retention. Chemical modification of Ag43β700-OMVs using lysozyme induces the shedding of OM sheets, releasing the cytosolic components. LD-Ag43β-OMVs had a morphology and diameter similar to those of nOMVs but were produced in higher yields. In general, nOMVs typically exhibit a low extraction yield (100 ng/108 colony forming units), which renders clinical application challenging (28). Increasing the yield of vesicles appears to be sufficiently feasible for clinical use as vaccines, drug delivery vehicles, and adjuvants (29, 30). For example, Park et al. developed an effective vaccine platform that can prevent Pseudomonas aeruginosa (P. aeruginosa) and SARS-CoV-2 infection by increasing the amount of OMV using a detergent-based OMV extraction method (31). Therefore, lysozyme digestion may be an improved method for isolating OMVs, with a faster isolation process and higher yield.

In conclusion, this study provides insights into the autonomous functionality of Ag43β in facilitating the expression of chimeric proteins, irrespective of the exterior/interior expression machinery. Notably, our findings highlight the pivotal role played by the interaction between α-HLD and periplasmic plug β-strands in enhancing the efficiency of this process. Moreover, our study demonstrates that LD-OMVs can be obtained in a significantly shorter timeframe and a greater yield than those for nOMVs. This not only streamlines the production process but also provides new avenues for leveraging OMVs in various applications. Furthermore, the remarkable biological activity displayed by the OMVs emphasizes their potential for pioneering surface display strategies, such as antigen target delivery. Overall, our results offer valuable insights into enhancing OMV-based platforms for a wide range of biochemical and molecular biological applications.

MATERIALS AND METHODS

Materials and methods are available in the Supplementary File.

ACKNOWLEDGEMENTS

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2020R1A6A1A06046235), the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through the Crop Viruses and Pests Response Industry Technology Development Program, funded by the Ministry of Agriculture, Food and Rural Affairs (MAFRA; No. 321108-04), and the Commercializations Promotion Agency for R&D Outcomes (COMPA) grant funded by the Korea government (MSIT; No. 1711173792).

CONFLICTS OF INTEREST

The authors have no conflicting interests.

FIGURES
Fig. 1. Comparison of surface display capabilities of Ag43β700_eGFP and Ag43β740_eGFP. (A) Schematic representation of the composition of E. coli Ag43 and surface display of the passenger domain. Each domain was identified via homology modeling of Ag43 using the PHYRE server (UK). The black arrow indicates the TU including a central α-HLD and β-barrel domain. (B) Detection of eGFP using flow cytometry. Recombinant variants were analyzed using an anti-FLAG primary antibody and Alexa FluorTM 647-conjugated secondary antibody. Recombinant bacterial cells expressing Ag43β variants were compared to BL21(DE3) cells expressing non-induced and induced eGFP. The x-axis represents the expression of FLAG on the cell surface, and the y-axis represents eGFP fluorescence. Q1, FLAG+eGFP+ cells; Q2, FLAGeGFP+ cells; Q3, FLAGeGFP cells; Q4, FLAG+eGFP cells; Controls, non-induced and induced eGFP. (C) Ag43β700_eGFP and Ag43β740_eGFP were analyzed using SDS-PAGE and western blotting, with (+) or without (−) trypsin treatment to release eGFP. Trypsin was used at a concentration of 1-2.5 μg/ml in PBS (pH 7.4) for treating equal numbers of recombinant bacterial cells at 37°C for 0-5 min. Untreated cells (marked with 0) served as the controls. Black arrows indicate recombinant eGFP, and M indicates the protein marker. (D) Structural insights into Ag43β-eGFP. The orientation of eGFP, whether exterior or interior, is strictly dependent on the presence or absence of α-HLD, respectively. eGFP is highlighted in green.
Fig. 2. Structures of TU and α-HLD predicted by MOE analysis. (A) Topology model of the TU. The TU not only contains the residues that make up strands β1 and β12 but also contains extra residues from their respective extracellular loops (eL1 to eL6) and periplasmic turns (pT1 to pT5). β1 and β12 strands are highlighted in green. Detailed amino acid sequences of the TU are shown on the right. (B) Predicted 3D structure of the TU. The side view of the TU shows a 12-stranded β-barrel (represented in gray and green). The periplasmic side is distinguished by short periplasmic turns (pT1-pT5), whereas the extracellular side features longer loops (eL1-eL6) connecting the alternating β-strands. An α-HLD (represented in red ribbon) is linked to β1 and positions the N-terminus of the translocator domain (R701) at the extracellular side. Black arrowheads indicate the locations of strand β1. The β1 and β12 strands (in green) form antiparallel hydrogen bond interactions. (C) Schematic diagram of the hydrogen bonding patterns of the internal pore-facing plug residues and their interactions with the β-barrel wall. The interacting residues are represented on a helical wheel with the diagram aligned in the same orientation as in (A). The five key interacting residues (* in (A), amino acid sequence) within the pore-facing plug may contribute to the formation of an inward kink in the C-terminal β-strand of the barrel. Pore-facing plug residues are shown in red, β-barrel residues in black, and β-barrel walls in blue. Distances between the α-HLD and barrel wall are indicated in (B).
Fig. 3. Detergent-treated OMVs and confirmation of surface display efficiency using eGFP. (A) Schematic representation of the procedure for isolating LD-Ag43β-OMVs from E. coli. (B) LD-OMV size distribution and concentration. Insets: cryo-TEM images utilized for determining LD-OMV morphology and size. Scale bar: 200 nm. (C) Extracellular trypsin treatment and western blot analysis of LD-OMVs. A significant decrease in eGFP signal was observed in LD-OMVs harboring Ag43β700_eGFP. (D) Quantitative RT-PCR results for the detection of various OMVs. Amplification curves of OMV isolates obtained using a lysozyme-based detergent [LD-OMVs (red line)] and ultracentrifugation [nOMVs (blue line)]. Whole bacteria [E. coli BL21(DE3), dotted black line] were used as the 16s rDNA positive control. Each amplification curve is one representative sample from experiments carried out in quintuplicates.
TABLE

Sizes and concentrations of LD-OMVs and nOMVs determined using tunable resistive pulse sensing analysis (qNano Gold) (n = 3)

LD-OMVs nOMVs
Particles/ml (5.6 ± 1.5) × 1013 (2.6 ± 1.5) × 106
Minimum 119.0 ± 7.2 119.3 ± 7.3
Maximum 326.0 ± 37.5 342.3 ± 29.9
Particle diameter (nm)
Mode 200.7 ± 12.5 208.0 ± 6.6
Mean 206.3 ± 11.7 215.3 ± 2.9

REFERENCES
  1. Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC and Ala'Aldeen D (2004) Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev 68, 692-744.
    Pubmed KoreaMed CrossRef
  2. Klemm P, Hjerrild L, Gjermansen M and Schembri MA (2004) Structure-function analysis of the self-recognizing antigen 43 autotransporter protein from Escherichia coli. Mol Microbiol 51, 283-296.
    Pubmed CrossRef
  3. Wells TJ, Tree JJ, Ulett GC and Schembri MA (2007) Autotransporter proteins: novel targets at the bacterial cell surface. FEMS Microbiol Lett 274, 163-172.
    Pubmed CrossRef
  4. Huang FY, Wang CC and Huang YH et al (2014) Antigen 43/Fcε3 chimeric protein expressed by a novel bacterial surface expression system as an effective asthma vaccine. Immunology 143, 230-240.
    Pubmed KoreaMed CrossRef
  5. Kjaergaard K, Hasman H, Schembri MA and Klemm P (2002) Antigen 43-mediated autotransporter display, a versatile bacterial cell surface presentation system. J Bacteriol 184, 4197-4204.
    Pubmed KoreaMed CrossRef
  6. Ramesh B, Sendra VG, Cirino PC and Varadarajan N (2012) Single-cell characterization of autotransporter-mediated Escherichia coli surface display of disulfide bond-containing proteins. J Biol Chem 287, 38580-38589.
    Pubmed KoreaMed CrossRef
  7. Heras B, Totsika M and Peters KM et al (2014) The antigen 43 structure reveals a molecular Velcro-like mechanism of autotransporter-mediated bacterial clumping. Proc Natl Acad Sci U S A 111, 457-462.
    Pubmed KoreaMed CrossRef
  8. Kalathiya U, Padariya M and Baginski M (2019) Structural, functional, and stability change predictions in human telomerase upon specific point mutations. Sci Rep 9, 8707.
    Pubmed KoreaMed CrossRef
  9. Shin WR, Park DY and Kim JH et al (2022) Structure based innovative approach to analyze aptaprobe-GPC3 complexes in hepatocellular carcinoma. J Nanobiotechnol 20, 204.
    Pubmed KoreaMed CrossRef
  10. Schwechheimer C and Kuehn MJ (2015) Outer-membrane vesicles from gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol 13, 605-619.
    Pubmed KoreaMed CrossRef
  11. Petousis-Harris H and Radcliff FJ (2019) Exploitation of Neisseria meningitidis Group B OMV vaccines against N. gonorrhoeae to inform the development and deployment of effective gonorrhea vaccines. Front Immunol 10, 683.
    Pubmed KoreaMed CrossRef
  12. Gujrati V, Kim S and Kim SH et al (2014) Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. Acs Nano 8, 1525-1537.
    Pubmed CrossRef
  13. Brown L, Wolf JM, Prados-Rosales R and Casadevall A (2015) Through the wall: extracellular vesicles in gram-positive bacteria, mycobacteria and fungi. Nat Rev Microbiol 13, 620-630.
    Pubmed KoreaMed CrossRef
  14. Bernadac A, Gavioli M, Lazzaroni JC, Raina S and Lloubes R (1998) Escherichia coli tol-pal mutants form outer membrane vesicles. J Bacteriol 180, 4872-4878.
    Pubmed KoreaMed CrossRef
  15. Schwechheimer C, Kulp A and Kuehn MJ (2014) Modulation of bacterial outer membrane vesicle production by envelope structure and content. BMC Microbiol 14, 324.
    Pubmed KoreaMed CrossRef
  16. van de Waterbeemd B, Streefland M and van der Ley P et al (2010) Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process. Vaccine 28, 4810-4816.
    Pubmed CrossRef
  17. Jing KJ, Guo YL and Ng IS (2019) Antigen-43-mediated surface display revealed in by different fusion sites and proteins. Bioresour and Bioprocess 6, 14.
    CrossRef
  18. Cheng KM, Zhao RF and Li Y et al (2021) Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug- and-Display technology. Nat Commun 12, 2041.
    Pubmed KoreaMed CrossRef
  19. Alves NJ, Turner KB, Medintz IL and Walper SA (2016) Protecting enzymatic function through directed packaging into bacterial outer membrane vesicles. Sci Rep 6, 24866.
    Pubmed KoreaMed CrossRef
  20. Kolling GL and Matthews KR (1999) Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl Environ Microbiol 65, 1843-1848.
    Pubmed KoreaMed CrossRef
  21. Tran F and Boedicker JQ (2017) Genetic cargo and bacterial species set the rate of vesicle-mediated horizontal gene transfer. Sci Rep 7, 8813.
    Pubmed KoreaMed CrossRef
  22. Huang Y, Nieh MP, Chen W and Lei Y (2022) Outer membrane vesicles (OMVs) enabled bio-applications: a critical review. Biotechnol Bioeng 119, 34-47.
    Pubmed CrossRef
  23. Cecil JD, O'Brien-Simpson NM and Lenzo JC et al (2017) Outer membrane vesicles prime and activate macrophage inflammasomes and cytokine secretion in vitro and in vivo. Front Immunol 8, 1017.
    Pubmed KoreaMed CrossRef
  24. Mancini F, Rossi O, Necchi F and Micoli F (2020) OMV vaccines and the role of TLR agonists in immune response. Int J Mol Sci 21, 4416.
    Pubmed KoreaMed CrossRef
  25. Song HW, Yoo G, Bong JH, Kang MJ, Lee SS and Pyun JC (2019) Surface display of sialyltransferase on the outer membrane of Escherichia coli and ClearColi. Enzyme Microb Technol 128, 1-8.
    Pubmed CrossRef
  26. van der Pol L, Stork M and van der Ley P (2015) Outer membrane vesicles as platform vaccine technology. Biotechnology Journal 10, 1689-1706.
    Pubmed KoreaMed CrossRef
  27. van de Waterbeemd B, Zomer G and Kaaijk P et al (2013) Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis. PLoS One 8, e65157.
    Pubmed KoreaMed CrossRef
  28. Shi R, Dong Z and Ma C et al (2022) High-yield, magnetic harvesting of extracellular outer-membrane vesicles from Escherichia coli. Small 18, e2204350.
    Pubmed CrossRef
  29. Collins SM and Brown AC (2021) Bacterial outer membrane vesicles as antibiotic delivery vehicles. Front in Immunol 12, 733064.
    Pubmed KoreaMed CrossRef
  30. Saraswat I, Saha S and Mishra A (2023) A review of metallic nanostructures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Toxicol Environ Health Sci 15, 315-324.
    CrossRef
  31. Park KS, Svennerholm K and Crescitelli R et al (2023) Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2. J Nanobiotechnol 21, 156.
    Pubmed KoreaMed CrossRef


This Article


Cited By Articles
  • CrossRef (0)

Author ORCID Information

Funding Information

Collections

Services
Social Network Service

e-submission

Archives